AX PHARMACEUTICAL CORP- dapsone powder

País: Estados Unidos

Língua: inglês

Origem: NLM (National Library of Medicine)

Ingredientes ativos:

DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302)

Disponível em:

AX Pharmaceutical Corp

DCI (Denominação Comum Internacional):

DAPSONE

Composição:

DAPSONE 49.5 g in 50 g

Via de administração:

NOT APPLICABLE

Status de autorização:

Bulk Ingredient For Animal Drug Compounding

Características técnicas

AX PHARMACEUTICAL CORP- DAPSONE POWDER
AX PHARMACEUTICAL CORP
----------
AX PHARMACEUTICAL CORP
dapsone powder
AX Pharmaceutical Corp
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-46 9
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
DAPSO NE (UNII: 8 W5C518 30 2) (DAPSONE - UNII:8 W5C518 30 2)
DAPSONE
49 .5 g in 50 g
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-46 9 -0 1
50 g in 1 JAR
0 8 /22/20 17
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
bulk ingredient fo r animal drug
c o mpo unding
0 8 /22/20 17
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
AX Pharmaceutical Co rp
20 29 248 58
repack(6 2157-46 9 ) , relabel(6 2157-46 9 )
Revised: 8/2017